COTINGA PHARMACEUTICALS INC COMMON SHAR (OTCMKTS:COTQF) Sellers Increased By 100% Their Shorts As Of Apr 16, 2018

April 16, 2018 - By Jane Lemasters

It was showed an increase on COTINGA PHARMACEUTICALS INC COMMON SHAR (OTCMKTS:COTQF)’s shares shorted with 100%. FINRA published in April COTQF’s total 200 shares shorted. Previously was reported up change of 100% from 100 shares. With Average volume 300, COTQF’s former position will take 1 days to recover.

The stock increased 20.92% or $0.0555 during the last trading session, reaching $0.3208.Cotinga Pharmaceuticals Inc. is after having 0.00% since April 16, 2017. COTQF has 310 volume or 2.65% up from normal. COTQF underperformed the S&P500 by 11.55%.

Cotinga Pharmaceuticals Inc., a biopharmaceutical company, develops therapies for the treatment of cancers.The firm is worth $6.01 million. The company's lead compound is COTI-2, a clinical stage small molecule targeting p53 proteins, as well as is in the Phase I clinical trial for the treatment of gynecologic cancers, and head and neck squamous cell carcinoma.Last it reported negative earnings. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: